The metabolic fate of potassium dodecyl [35S]sulphate was studied in rats. Intraperitoneal and oral administration of the ester into free-ranging animals were followed by the excretion of the bulk of the radioactivity in the urine within 12 hr., approximately 17% being eliminated as inorganic [35S] 
Dodecyl sulphate is widely used commercially (Allen, 1962 ) because of its surface-active properties. As a result of its widespread use in industrial and domestic preparations a number of studies (e.g. Epstein, Throndson, Dock & Tainter, 1939; Cascorbi, Rudo & Lu, 1963; Walker, Brown, Ferrigan, Pickering & Williams, 1967) of the toxicity of the ester have been reported. Its biological degradability in sewage and industrial waste bymicro-organismshas also received attention (e.g. Bogan & Sawyer, 1955 Okey, Cohen & Chapman, 1964; de Long, 1964) , but no metabolic studies with identification of the products of degradation have been reported. Further, no study of the metabolic fate of dodecyl sulphate appears to have been carried out in mammals.
The present work on the metabolism of potassium dodecyl [35S] sulphate in rats shows that the ester undergoes relatively little desulphation, but is metabolized to yield a major product that has been identified as the sulphate ester of 4-hydroxybutyric acid.
MATERIALS AND METHODS Potassium dodecyl [35S] sulphate. This was prepared by a modification of the method of Kloubeck & Kondelik (1963) . Dodecan-l-ol was obtained from Britigh Drug Houses Ltd. (Poole, Dorset) and distilled (b.p. 257-261°) before use.
[35S]Sulphuric acid (0-290g., specific radioactivity 6-4mc/ m-mole, obtained from The Radiochemical Centre, Amersham, Bucks.) was added dropwise with stirring to a cooled (-15°) solution of dodecan-l-ol (0.55g.) in 10ml. of light petroleum (b.p. 40-60°). After continuous stirring over a period of 4 hr. at -150 the whole mixture was allowed to attain room temperature. Thionyl chloride (0.350g.) was added to remove water produced during the reaction and the resultant SO2 and HCI were removed in a stream of N2. Light petroleum was removed by evaporation in vacuo at room temperature, the residual gum was dissolved in dry methanol (25 ml.) and the solution was neutralized with KOH (5%, w/v, in dry methanol) with ethanolic phenolphthalein as external indicator. Precipitated K2504 was removed by centrifuging and washed with 40 ml. of methanol at 50°. The washings and supernatant were combined and, after the addition of 10vol. of ether, the mixture was stored overnight at 4°. Precipitated potassium dodecyl [35S] sulphate was collected by centrifuging, washed with ether (total volume 20ml.) and recrystallized twice from boiling water before being dried in vacuo over P205. The yield was 300mg. and the specific radioactivity 6 4mclm-mole. Thin-layer chromatography on silica gel G with solvent A, butan-l-ol-acetic acid-water (4::1 :1, by vol.) (RF of the product 0 69), and with solvent B, benzene-butan-2-one-ethanol-water (1:1:2:1, by vol.) (RF of the product 0-73), showed the product to be homogeneous and free from inorganic [35S] sulphate. Infrared analysis (see below) showed the product to have an 43 absorption spectrum identical with that of authentic dodecyl sulphate (Chihara, 1960 The product was shown to be homogeneous by descending paper chromatography on Whatman no. 1 paper with solvent A and with solvent C, isobutyric acid-O 5N-NH3 (5:3, vfv); its Rp in solvent A was 0-24 and in solvent C 0-36; and by thin-layer chromatography with solvent A (RF 045), with solvent D, butan-l-ol-acetic acid-water (3:1:1, by vol.) (RF 0 49), and with solvent E, propan-2-olwater (3:2, v/v) (Rp 0.68).
A 35S-labelled sample ofpotassium butyric acid 4-sulphate was prepared as described above except that pyridine-35SO3 (0-41g.) was mixed with 0-315g. of sodium 4-hydroxybutyrate and stirred in 25 ml. of dry pyridine. The yield was 66mg. and the specific radioactivity 3-3 mc/m-mole. Potassium Chromatography. Paper chromatograms were usually run overnight on Whatman no. 1 paper, and thin-layer chromatograms on silica gel G were run over a distance of 12cm. Sulphate esters were detected on paper chromatograms with rhodizonate reagent by the method of Schneider & Lewbart (1956) and on thin-layer chromatograms with fluorescein (0-2%, w/v, in ethanol).
Radioactive areas on chromatograms were detected either by radioautography on Ilford Industrial B X-ray film for 7-18 days, or by scanning with a Packard Radiochromatogram Scanner (model 7200). The relative amount of radioactivity associated with each spot was measured from the record of the scanner as described by Jones & Dodgson (1965) . Gas-chromatographic analysis was carried out with a Perkin-Elmer F-11 gas chromatograph fitted with dual flame-ionization detectors. The glass columns (6ft. x 0-25in.) were packed with diethylene glycol succinate on hexamethyldisilazane-treated Chromosorb W (80-100 mesh) (3:22, by wt.). All samples were examined isothermally at 1300 with the injection-point heaters at 2400.
The rate of flow of N2 carrier gas was 22ml./min.
Paper electrophoresis. Compounds were run horizontally as spots on Whatman no. 1 paper with 0-1 M-sodium acetate-acetic acid buffer, pH4-5, for 1-5hr. at a potential gradient of 13v/cm. Radioactive areas were located by radioautography.
Infrared spectroscopy. The spectra of the esters were determined with a Perkin-Elmer 137 Infracord recording spectrophotometer, the esters being examined as mulls in Nujol (liquid paraffini).
Experimental animals. Adult male and female M.R.C. hooded rats were used throughout unless otherwise stated. Intraperitoneal injections of the esters were carried out while the animals were under ether anaesthesia. The animals were placed in metabolism cages that permitted separate collection of urine and faeces, and were allowed water without restriction and food after 24hr. Urine samples were collected after 6, 12, 24 and 48hr., funnel washings being added to the appropriate sample.
In some experiments, the esters were administered by stomach tube to rats under light ether anaesthesia, and urine and faeces were collected as described. Similar experiments were made in which animals had received prior treatment with antibiotics (see Dodgson, Powell, Rose & Tudball, 1961) .
In experiments on rats with bile-duct and ureter cannulae, animals were anaesthetized with ether, the jugular vein was cannulated and Nembutal (10-15mg./kg. body wt.) was administered by the cannula. The bile duct and ureters were cannulated and bile and urine samples collected at suitable times after administration of the ester by the jugular-vein cannula. Animals were maintained under Nembutal anaesthesia throughout the experiments.
Whenever possible, urine and bile samples were assayed for radioactivity immediately; otherwise they were stored at 40 until required.
Measurement of radioactivity in biological materials. Purification of metabolite A Ten male rats were each injected intraperitoneally with potassium dodecyl [35S]sulphate (1mg. dissolved in 1 ml. of water); urine was collected over 24 hr. and pooled together with funnel washings (total volume approx. 400 ml.). Thin-layer chromatography (solvernt A) and subsequent scanning of a sample (20,u1.) of the pooled urine revealed that metabolite A represented approx. 75% of the injected radioactivity. The urine was passed through a column (7-0cm. x 1-1cm.) of Dowex 1 ion-exchange resin (X4; 50-100 mesh; C1-form) at a flow rate of about 60ml./hr., and all the radioactivity was retained by the resin. The column was eluted with 0-1M-potassium chloride (15ml.) at a flow rate of approx. 30ml./hr. Successive elution with 15 ml. portions of 0-2M-, 0-4M-, 0-6M-, 0-8 M-and 1-OM-potassium chloride was carried out.
The bulk of the radioactivity (90%) was found in the 0-6M-and 0-8M-potassium chloride eluates, and these eluates were combined and concentrated to about 10ml. in vacuo at 37°. This solution was applied to a column (50-0 cm. x 1-2 cm.) of Sephadex G-10, which was subsequently eluted with water at a flow rate of 25ml./hr. The void volume of the column was discarded and successive fractions (0-5ml.) were collected and checked for radioactivity and the presence of Cl-ion. Fractions that contained radioactivity and were essentially free from Cl-ions (usually fractions 14-28) were combined and concentrated in vacuo at 37°to approx. 1 ml. This solution was applied, as a streak, to a thick-layer plate (thickness 1.25mm.) of silica gel G, which was developed in solvent E. Metabolite A was located by radioautography (4hr. exposure) and the appropriate area of silica gel was removed and extracted with water (15 ml.). After centrifugation to remove silica gel, the eluate was concentrated to 4ml. in vacuo at 370 and insoluble material was removed by centrifuging. Thin-layer chromatography with solvent A showed the solution to contain metabolite A as the single radioactive component. The solution was applied to a column (40.0cm. x 1-2cm.) of Sephadex G-25 (fine grade), and metabolite A was eluted with water at a flow rate of approx. 25ml./hr. The void volume of the column was discarded and successive fractions (0.5ml.) were collected and assayed for radioactivity. Fractions containing metabolite A were combined (usually fractions 22-36, total vol. 7.5 ml.) and stored at 4°. About 60% of the radioactive ester sulphate fraction of the original urine was present in the final solution of metabolite A. This solution contained a single radioactive component when subjected to thin-layer chromatography in solvents A, B and E.
The possible presence of non-radioactive contaminants in the preparation was investigated by spraying a series of chromatograms with concentrated sulphuric acid, phosphomolybdic acid in (20,u1.) to silicagel plates together with the following authentic markers: potassium butyric acid 4-sulphate, potassium propionic acid 3-sulphate and potassium glycollic acid sulphate. After development with solvents A, D and E, radioautograms were prepared and the esters were subsequently rendered visible on the chromatograms with the fluorescein reagent. In all solvent systems the radioactive spot (metabolite A) coincided with the coloration produced by the fluorescein reagent. Further, the mobility of metabolite A was identical with that of potassium butyric acid 4-sulphate and distinct from the mobilities of the other marker ester sulphates (see Table 3 ).
Further experiments were carried out in which purified metabolite A was applied as spots (20 ,ul.) to Whatman no. 1 paper together with the authentic markers previously used. Chromatograms were developed with solvents A and C. Radioautograms were prepared and the esters were rendered visible by the rhodizonate reagent. The radioactive spot (metabolite A) coincidedwitha rhodizonate-positive spot. The mobility of metabolite A again coincided with that of potassium butyric acid 4-sulphate (see Table 3 ).
Ga8 chromatography. Purified metabolite A (1 ml.) was diluted to 15 ml. with water and mixed with 5ml. of 4 N-hydrochloric acid. The solution was heated at 1100 for 16 hr. (a time-hydrolysis curve for metabolite A showed complete hydrolysis after 16 hr.) after which it was extracted with four 20ml. lots of benzene. The benzene extract was concentrated in vacuo at room temperature to about 20 pl. and portions (1 ,ul.) were applied through the rubber septum directly into the chromatographic column. The following controls (1l,. portions in each case) were also subjected to the analytical procedure: (a) benzene (80 ml.) evaporated to a volume of approx. 20 ,tl.; (b) a benzene extract (four 20ml. lots, evaporated to approx. 201l.) of unhydrolysed purified metabolite A (l ml. diluted to 15 ml. with water). For purposes of comparison, authentic y-butyrolactone (lml.) was mixed with benzene (9ml.) and portions (1,il.) were analysed by gas chromatography.
Three major peaks were obtained with the Whole-body radioautography
The most striking feature of the whole-body radioautograms was the cellular accumulation of radioactivity in the liver. Thus radioautograms of animals killed 5min. after injection showed significant amounts of radioactivity within the liver, although a considerable amount of the 35S remained in the intraperitoneal cavity, the site of injection. The concentration of radioactivity in the liver increased up to 30min. and then gradually declined, and only trace amounts remained after 4hr. In all the radioautograms only traces of radioactivity were associated with the circulating blood. Apart from the liver, the kidney was the only other organ in which any appreciable cellular accumulation was recorded.
These observations demonstrated that, after the administration of dodecyl [35S]sulphate, liver and kidney were the only organs that became labelled to any significant extent. The appearance of radioactivity in the kidney might reflect the urinary excretion of 35S, and the ability of the cells of the liver to accumulate radioactivity might implicate the liver as the major site of metabolism of dodecyl [35S]sulphate.
Liver-perfusion experiments The experiments described above indicated that potassium dodecyl [35S]sulphate was metabolized in the liver in the intact animal. To confirm this, isolated rat livers were perfused with blood containing 10mg. of potassium dodecyl [35S]sulphate. A sample of the perfusate was withdrawn from the system before the insertion ofthe liver and incubated at 370 for the duration of the experiment. No hydrolysis occurred in this control sample. After insertion of the liver, samples of blood (0 5 ml.) were collected at zero time, after 15min., 30min. and 1 hr., and after every following hour, and bile samples (approx. 0-6ml.) were collected hourly. The blood samples were centrifuged to remove erythrocytes; preliminary experiments showed that no significant amounts of radioactivity sedimented with the erythrocytes. Portions (5 ,ul.) of the supernatants were subjected to thin-layerchromatography in solvent A. Previous work on the degradation of long-chain hydrocarbons and their derivatives by microorganisms (e.g. Foster, 1962; Treccani, 1963) has shown that these compounds are degraded by a process involving initial co-oxidation followed by ,-oxidation of the fatty acids so produced. Similar degradative pathways have been reported in mammals, and enzyme systems involved in the co-oxidation of fatty acids and their derivatives have been found in liver (Wakabayashi & Shimazono, 1963; Preiss & Bloch, 1964) and kidney (Robbins, 1968) . The mechanism of co-oxidation apparently involves first the conversion of the monocarboxylic acid into the c-hydroxy acid by direct hydroxylation of the co-methyl group. Subsequently the co-hydroxy acid is converted into the oxo acid and finally into the dicarboxylic acid, which is then degraded by ,-oxidation (Den, 1965 Since dodecyl sulphate is extensively used in a number of industrial and domestic preparations these studies on the metabolism of the ester have a number of implications. It is shown that the ester is extensively metabolized in rats to yield butyric acid 4-sulphate, and the same degradative pathway may operate in both micro-organisms and in man. Rigorous studies on the toxicity of dodecyl sulphate have been carried out, but there is no available information on the relative toxicity of butyric acid 4-sulphate. Further, the present studies have shown that some degradation of butyric acid 4-sulphate with the liberation of inorganic sulphate occurs in the rat. It may be that desulphation is accompanied by the simultaneous production of 4-hydroxybutyric acid, which has been shown to depress the central nervous system in rats (Giarman & Roth, 1964 
